Rosuvastatin protects against coronary microembolization-induced cardiac injury via inhibiting NLRP3 inflammasome activation

Coronary microembolization (CME), a common reason for periprocedural myocardial infarction (PMI), bears very important prognostic implications. However, the molecular mechanisms related to CME remain largely elusive. Statins have been shown to prevent PMI, but the underlying mechanism has not been i...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cell Death Dis
Autori principali: Chen, Ao, Chen, Zhangwei, Zhou, You, Wu, Yuan, Xia, Yan, Lu, Danbo, Fan, Mengkang, Li, Su, Chen, Jinxiang, Sun, Aijun, Zou, Yunzeng, Qian, Juying, Ge, Junbo
Natura: Artigo
Lingua:Inglês
Pubblicazione: Nature Publishing Group UK 2021
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7804109/
https://ncbi.nlm.nih.gov/pubmed/33436548
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41419-021-03389-1
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi